Benitec Biopharma (BNTC) Profit After Tax (2019 - 2025)
Benitec Biopharma (BNTC) reported Profit After Tax of -$133000.0 for Q4 2025, up 93.94% on a YoY basis from -$68577.6 in Q4 2024, and up 98.52% sequentially from -$9.0 million in Q3 2025.
Benitec Biopharma (BNTC) Profit After Tax (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Profit After Tax data on file, last reported at -$133000.0 in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax rose 93.94% year-over-year to -$133000.0; the trailing twelve-month figure through Dec 2025 stood at -$27.3 million (down 127.1% YoY), and the FY2025 full-year result was -$37.9 million, down 73.93% from the prior year.
- Profit After Tax rose to -$133000.0 in Q4 2025, from -$9.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $117000.0 in Q1 2024 to a low of -$20.0 million in Q2 2023.
- A 5-year average of -$5.4 million and a median of -$5.0 million in 2021 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax slumped 13545.83% in 2022 and soared 102.69% in 2024, its largest moves.
- Tracing BNTC's Profit After Tax over 5 years: stood at -$4.8 million in 2021, then dropped by 12.24% to -$5.4 million in 2022, then slipped by 25.63% to -$6.8 million in 2023, then jumped by 67.71% to -$2.2 million in 2024, then surged by 93.94% to -$133000.0 in 2025.
- Business Quant data shows BNTC's Profit After Tax at -$133000.0 in Q4 2025, -$9.0 million in Q3 2025, and -$8.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | -133,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -133,000.00 |
| Sep 30, 2025 | -8.97 Mn |
| Jun 30, 2025 | -8.81 Mn |
| Mar 31, 2025 | -9.35 Mn |
| Dec 31, 2024 | -2.20 Mn |
| Sep 30, 2024 | -5.16 Mn |
| Jun 30, 2024 | -4.76 Mn |
| Mar 31, 2024 | 117,000.00 |
| Dec 31, 2023 | -6.80 Mn |
| Sep 30, 2023 | -5.95 Mn |
| Jun 30, 2023 | -19.99 Mn |
| Mar 31, 2023 | -4.35 Mn |
| Dec 31, 2022 | -5.41 Mn |
| Sep 30, 2022 | -5.09 Mn |
| Jun 30, 2022 | -5.02 Mn |
| Mar 31, 2022 | -3.28 Mn |
| Dec 31, 2021 | -4.82 Mn |
| Sep 30, 2021 | -5.05 Mn |
| Jun 30, 2021 | -3.48 Mn |
| Mar 31, 2021 | -24,000.00 |